Parallax Health Sciences, Inc. announced that the company has approved the design and development of Compass-ASD Version 2.0 mobile app and Parallax Care provider platform targeting the treatment of Autism. The Compass ASD 2.0 Parallax Care provider platform and Patented Reliable Evidenced Based Outcome Optimization Technology, (“REBOOT”) was developed, tested and commercially deployed, at a cost of approximately $4 million at Grafton Integrated Health Network.